Abstinence-contingent wage supplements to promote drug abstinence and employment: Post-intervention outcomes

dc.contributor.authorNovak, Matthew
dc.contributor.authorHoltyn, August F.
dc.contributor.authorToegel, Forrest
dc.contributor.authorLeoutsakos, Jeannie-Marie
dc.contributor.authorSilverman, Kenneth
dc.date.accessioned2024-03-21T23:02:58Z
dc.date.available2024-03-21T23:02:58Z
dc.date.issued2022-01-20
dc.description.abstractBackground Substance use disorder, unemployment, and poverty are interrelated problems that have not been addressed adequately by existing interventions. This study evaluated post-intervention effects of abstinence-contingent wage supplements on drug abstinence and employment. Methods Unemployed adults enrolled in opioid agonist treatment were randomly assigned to an abstinence-contingent wage supplement group (n = 44) or a usual care control group (n = 47). All participants could work with an employment specialist throughout a 12-month intervention period. Those in the abstinence-contingent wage supplement group earned stipends for working with the employment specialist and, after gaining employment, abstinence-contingent wage supplements for working in their community job but had to provide opiate- and cocaine-negative urine samples to maximize pay. To assess post-intervention effects of abstinence-contingent wage supplements and compare those effects to during-intervention effects, we analyzed urine samples and self-reports every 3 months during the 12-month intervention and the 12-month post-intervention period. Results During the intervention, abstinence-contingent wage supplement participants provided significantly more opiate- and cocaine-negative urine samples than usual care control participants; abstinence-contingent wage supplement participants were also significantly more likely to become employed and live out of poverty than usual care participants during intervention. During the post-intervention period, the abstinence-contingent wage supplement and usual care control groups had similar rates of drug abstinence, similar levels of employment, and similar proportions living out of poverty. Conclusions Long-term delivery of abstinence-contingent wage supplements can promote drug abstinence and employment, but many patients relapse to drug use and cease employment when wage supplements are discontinued.
dc.description.sponsorshipThis research was supported by the National Institute on Drug Abuse of the National Institutes of Health under grants R01 DA037314 and T32 DA07209. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The National Institutes of Health had no part in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
dc.description.urihttps://www.sciencedirect.com/science/article/abs/pii/S037687162200059X
dc.format.extent17 pages
dc.genrejournal articles
dc.genrepostprints
dc.identifierdoi:10.13016/m2qblt-onaw
dc.identifier.urihttps://doi.org/10.1016/j.drugalcdep.2022.109322
dc.identifier.urihttp://hdl.handle.net/11603/32411
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Psychology Department Collection
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleAbstinence-contingent wage supplements to promote drug abstinence and employment: Post-intervention outcomes
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0002-2889-2819

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
nihms-1773860.pdf
Size:
460.21 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
NIHMS1773860-supplement-1.pdf
Size:
93.46 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.56 KB
Format:
Item-specific license agreed upon to submission
Description: